A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: SHR-1210|DRUG: Apatinib
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University